Literature DB >> 16708548

Pineal parenchymal tumors of intermediate differentiation in adults: case report and literature review.

Marc Pusztaszeri1, Alessia Pica, Robert Janzer.   

Abstract

Pineal parenchymal tumors (PPT), including pineoblastomas, are very uncommon, especially in adults. Because of the small number of reported cases, the histological and biological features of these tumors are still being defined, as is their optimal management. Also, the pathological variability of these tumors makes it difficult to draw general conclusions about their behavior. We report the case of a PPT of intermediate differentiation (PPTID) with an excellent outcome. A 3.2 cm tumor in the pineal and tectal region with obstructive hydrocephalus was found in a 28-year-old female complaining of headaches and hypoesthesia of the right side of the face. Stereotactic biopsy revealed a highly cellular tumor composed of small cells that contained little cytoplasm that were arranged in a diffuse pattern. Mitotic activity was low and there was no evidence of necrosis. Immunohistochemical examination demonstrated positive staining for neuron-specific enolase and synaptophysin. There was no expression of neurofilaments or GFAP. Ki-67 proliferation index was 12%. The diagnosis was a PPTID. Treatment consisted of combined neoadjuvant chemotherapy and craniospinal radiotherapy. Six years after treatment, the patient is alive and free of any clinical or radiological signs of relapse. This paper discusses the pathological and biological features of these tumors and the treatment options available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708548     DOI: 10.1111/j.1440-1789.2006.00657.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  7 in total

1.  Pineal parenchymal tumor of intermediate differentiation with papillary features: a continuum of primary pineal tumors?

Authors:  Jessica N Cohan; Jennifer A Moliterno; Christina L Mok; Ehud Lavi; John A Boockvar
Journal:  J Neurooncol       Date:  2010-06-03       Impact factor: 4.130

Review 2.  Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.

Authors:  Hajime Takase; Reo Tanoshima; Navneet Singla; Yoshihiko Nakamura; Tetsuya Yamamoto
Journal:  Neurosurg Rev       Date:  2021-10-20       Impact factor: 3.042

3.  Arterial vascularization of the pineal gland.

Authors:  Gokmen Kahilogullari; Hasan Caglar Ugur; Ayhan Comert; Recep Ali Brohi; Onur Ozgural; Mevci Ozdemir; Suleyman Tuna Karahan
Journal:  Childs Nerv Syst       Date:  2013-01-20       Impact factor: 1.475

4.  Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN).

Authors:  Salvador Villà; Robert C Miller; Marco Krengli; Huda Abusaris; Brigitta G Baumert; Stephanie Servagi-Vernat; Sefik Igdem; Anna Lucas; Susanna Boluda; René O Mirimanoff
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

5.  Quantitative imaging values of CT, MR, and FDG-PET to differentiate pineal parenchymal tumors and germinomas: are they useful?

Authors:  Takahide Kakigi; Tomohisa Okada; Mitsunori Kanagaki; Akira Yamamoto; Yasutaka Fushimi; Ryo Sakamoto; Yoshiki Arakawa; Yoshiki Mikami; Taro Shimono; Jun C Takahashi; Kaori Togashi
Journal:  Neuroradiology       Date:  2014-02-09       Impact factor: 2.804

6.  Pineal parenchymal tumor of intermediate differentiation: diagnostic pitfalls and discussion of treatment options of a rare tumor entity.

Authors:  Christian Senft; Andreas Raabe; Elke Hattingen; Daniel Sommerlad; Volker Seifert; Kea Franz
Journal:  Neurosurg Rev       Date:  2008-02-12       Impact factor: 3.042

7.  Successful treatment by chemotherapy of pineal parenchymal tumor with intermediate differentiation: a case report.

Authors:  Ji-Won Yi; Hyo-Jeong Kim; Young-Jin Choi; Young-Mi Seol; Dong-Hwahn Kahng; Yu-Yi Choi; Eun-Kyoung Park
Journal:  Cancer Res Treat       Date:  2013-09-30       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.